Skip to main content
P.H. flag

Unofficial COVID-19 PH Tracker

Icon by icons8.com

disease.sh - Open Disease Data
Sourced data from Johns Hopkins University, the New York Times, Worldometers, and Apple reports to give you a comprehensive view of the data.

Image of Vicente G. Reyes

Developed by Vicente G. Reyes
A Self-Directed Learner, a Freelance Web Developer, a Volunteer Developer at Project Website, Moderator at DEV, & a Podcast host. www.vgreyes.com

  • Here's Why Relmada Therapeutics Stock Popped Today

    Date published: 2021-07-27

    Shares of Relmada Therapeutics (NASDAQ: RLMD), a clinical-stage biopharmaceutical company, popped in response to a positive clinical trial readout with the...

  • Sorrento Therapeutics Announces the Formation of Sorrento Therapeutics Mexico for Commercialization of COVI-STIX and Development of Sorrento's Portfolio of COVID-19 Products in Mexico and Parts of Latin America

    Date published: 2021-07-20

    Sorrento Therapeutics has established a Subsidiary Company in Mexico - Sorrento Therapeutics Mexico. Sorrento's Mexican importer of record has received an ...

  • Why Sorrento Therapeutics Is Down 9% This Week

    Date published: 2021-07-08

    This is not a good week to be Sorrento Therapeutics (NASDAQ: SRNE) or one of its investors. Tuesday afternoon, Sorrento announced that the U.S. Food and...

  • This Therapeutics Company Is Eyeing Zero Competition for the Next 5 Years

    Date published: 2021-07-03

    If production setbacks can be avoided, gains should be in sight.

  • Lag between COVID-19 vaccine boosters, new variants highlight need for therapeutics, expert says

    Date published: 2021-06-09

    While work on COVID-19 vaccine boosters is already underway, one expert warned that emerging variants threaten to create a "window of susceptibility," which without therapeutics could lead to more virus-inflicted death.

  • Independent Data Safety Monitoring Board Recommends Appili Therapeutics Complete Its Phase 3 Avigan/Reeqonus Trial for Mild-to-Moderate COVID-19 Patients

    Date published: 2021-05-17

    /PRNewswire/ -- Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for...

  • Analyzing Sorrento Therapeutics (NASDAQ:SRNE) & Eiger BioPharmaceuticals (NASDAQ:EIGR)

    Date published: 2021-04-24

    Sorrento Therapeutics (NASDAQ:SRNE) and Eiger BioPharmaceuticals (NASDAQ:EIGR) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Volatility and Risk Sorrento Therapeutics has a beta of 2.7, meaning that its share price is []

  • New Phase 3 trial of therapeutics begins enrolling severely ill hospitalized COVID-19 patients

    Date published: 2021-04-22

    A new Phase 3 trial to test the safety and efficacy of therapeutics for COVID-19 has begun enrolling patients hospitalized with life-threatening cases of COVID-19, including those with acute respiratory failure.

  • Qualigen Therapeutics Plans to Combat COVID-19 Variants

    Date published: 2021-04-19

    Qualigen Therapeutics Inc (NASDAQ: QLGN) was one of the sponsors for the Benzinga Biotech Global Small Cap Conference that took place on March 24-25, 2021. ...

  • San Diego Therapeutics Company Battles COVID-19 Variants NBC 7 San Diego

    Date published: 2021-03-09

    A San Diego company says it's leading the charge in the race to get ahead of dangerous COVID-19 variants.